Diagnos Inc (DGNOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,297 | -3,081 | -2,313 | -1,877 | -2,081 |
| Depreciation Amortization | 94 | 92 | 92 | 65 | 78 |
| Accounts receivable | -30 | -3 | 72 | 63 | -114 |
| Other Working Capital | -52 | -174 | 114 | 66 | -12 |
| Other Operating Activity | 569 | 551 | 444 | 258 | 503 |
| Operating Cash Flow | $-2,717 | $-2,614 | $-1,592 | $-1,425 | $-1,626 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,171 | -2,228 | 0 | 378 | 399 |
| PPE Investments | -8 | -10 | -8 | -18 | -25 |
| Sale Of Investment | 3,257 | N/A | N/A | N/A | 24 |
| Other Investing Activity | 53 | 3 | -2 | -1 | 4 |
| Investing Cash Flow | $1,131 | $-2,235 | $-10 | $359 | $402 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -158 | 626 | 1,218 | 798 |
| Debt Repayment | -554 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 2,601 | 5,234 | 1,213 | N/A | 578 |
| Other Financing Activity | -301 | -321 | -293 | -246 | -103 |
| Financing Cash Flow | $1,746 | $4,756 | $1,545 | $972 | $1,273 |
| Exchange Rate Effect | 1 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 64 | 157 | 220 | 318 | 287 |
| End Cash Position | 224 | 64 | 162 | 224 | 336 |
| Net Cash Flow | $160 | $-94 | $-58 | $-94 | $49 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,717 | -2,614 | -1,592 | -1,425 | -1,626 |
| Capital Expenditure | -8 | -10 | -8 | -18 | -25 |
| Free Cash Flow | -2,725 | -2,624 | -1,600 | -1,443 | -1,651 |